Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,259,643
+$3,943,145 QoQ
Shares Held
237,042
+1529.7% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,908,415,112 across 370 Biotechnology names. SRPT ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,259,643 | 237,042 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $316,498 | 14,545 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $361,664 | 16,806 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $276,986 | 14,374 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $140,134 | 8,195 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,963,437 | 422,492 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $84,245,573 | 692,866 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $154,331,816 | 1,235,742 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $293,966,110 | 1,860,545 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $174,585,870 | 1,348,570 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $145,326,180 | 1,507,064 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $231,682,086 | 1,911,253 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $206,574,381 | 1,803,828 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $364,512,935 | 2,644,656 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $351,948,477 | 2,716,071 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $281,857,986 | 2,549,828 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $124,946,026 | 1,666,836 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $121,080,999 | 1,549,936 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $260,908,437 | 2,897,373 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $383,925,908 | 4,151,448 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $344,170,369 | 4,427,198 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $330,142,036 | 4,429,653 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,028,802,979 | 6,034,389 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $890,845,226 | 6,343,696 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,254,637,089 | 7,824,854 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $725,315,146 | 7,414,794 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||